Core Laboratories (CLB) Projected to Post Earnings on Wednesday

by · The Cerbat Gem

Core Laboratories (NYSE:CLB – Get Free Report) is projected to release its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect Core Laboratories to post earnings of $0.20 per share and revenue of $130.4020 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Core Laboratories Price Performance

Core Laboratories stock opened at $19.56 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36. The firm has a market cap of $910.90 million, a PE ratio of 29.20, a price-to-earnings-growth ratio of 17.05 and a beta of 1.09. The company’s 50 day moving average is $17.43 and its two-hundred day moving average is $14.32.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $12.50.

Check Out Our Latest Report on CLB

Institutional Trading of Core Laboratories

Institutional investors have recently bought and sold shares of the business. Platinum Investment Management Ltd. boosted its position in shares of Core Laboratories by 3.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock worth $294,000 after acquiring an additional 889 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Core Laboratories by 6.2% during the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after purchasing an additional 1,040 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Core Laboratories by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock valued at $418,000 after purchasing an additional 1,170 shares in the last quarter. Quarry LP increased its stake in Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the last quarter. Finally, Sei Investments Co. increased its stake in Core Laboratories by 12.7% in the third quarter. Sei Investments Co. now owns 22,643 shares of the oil and gas company’s stock valued at $280,000 after purchasing an additional 2,550 shares during the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.

Read More